Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Brunner

Showing results (361-370 of 564) with videos related to

Pageof 57
Sort By:
Chest|July 1, 1984
Renin and the complications of acute myocardial infarctionC Vaney, B Waeber, G Turini, et al.
Archives of Internal Medicine|November 1, 1977
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?H Gavras, I Gavras, P J Cannon, et al.
Hypertension (Dallas, Tex. : 1979)|March 19, 1999
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonistsL Mazzolai, M Maillard, J Rossat, et al.
Journal of Clinical Hypertension|December 1, 1987
Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diureticV Mooser, G Waeber, J Bidiville, et al.
Schweizerische Medizinische Wochenschrift|March 12, 1983
[Profiles and variations of ambulatory arterial pressure in treated and untreated hypertensive patients]B Jacot des Combes, B Waeber, M Porchet, et al.
Regulatory Peptides|December 15, 1994
Interactions between NPY and its receptor: assessment using ant-NPY antibodiesE Grouzmann, F Cressier, P Walker, et al.
Circulation|November 1, 1978
Angiotensin converting enzyme inhibition in patients with congestive heart failureH Gavras, D P Faxon, J Berkoben, et al.
The American Journal of Physiology|June 1, 1987
Postpropranolol vasodilation in adrenalectomized glucocorticoid hypertensive ratsD J DiPette, J F Burris, A Rogers, et al.
Lancet (London, England)|September 12, 1981
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421"H Gavras, J Biollaz, B Waeber, et al.
Journal of Clinical Pharmacology|March 1, 1986
Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humansA Rakhit, M E Hurley, V Tipnis, et al.
Pageof 57

Showing results (361-370 of 564) with videos related to

Sort By:
Pageof 57
Chest|July 1, 1984
Renin and the complications of acute myocardial infarctionC Vaney, B Waeber, G Turini, et al.
Archives of Internal Medicine|November 1, 1977
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?H Gavras, I Gavras, P J Cannon, et al.
Hypertension (Dallas, Tex. : 1979)|March 19, 1999
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonistsL Mazzolai, M Maillard, J Rossat, et al.
Journal of Clinical Hypertension|December 1, 1987
Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diureticV Mooser, G Waeber, J Bidiville, et al.
Schweizerische Medizinische Wochenschrift|March 12, 1983
[Profiles and variations of ambulatory arterial pressure in treated and untreated hypertensive patients]B Jacot des Combes, B Waeber, M Porchet, et al.
Regulatory Peptides|December 15, 1994
Interactions between NPY and its receptor: assessment using ant-NPY antibodiesE Grouzmann, F Cressier, P Walker, et al.
Circulation|November 1, 1978
Angiotensin converting enzyme inhibition in patients with congestive heart failureH Gavras, D P Faxon, J Berkoben, et al.
The American Journal of Physiology|June 1, 1987
Postpropranolol vasodilation in adrenalectomized glucocorticoid hypertensive ratsD J DiPette, J F Burris, A Rogers, et al.
Lancet (London, England)|September 12, 1981
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421"H Gavras, J Biollaz, B Waeber, et al.
Journal of Clinical Pharmacology|March 1, 1986
Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humansA Rakhit, M E Hurley, V Tipnis, et al.
Pageof 57